#95 - Peptides Are Everywhere, But Are They Legal? Why Doctors Can't Prescribe What Everyone Else Is Selling

From Telemedicine Talks · 00:23:48

Show by Phoebe Gutierrez, Dr. Leo Damasco, Doctor Podcast Network

In this solo episode of Telemedicine Talks, Phoebe walks through the current state of peptides in digital health. She covers the three pathways peptides reach patients (FDA-approved, 503A compounding, and research use only), the critical differences between 503A and 503B pharmacies, and the timeline of FDA actions from the 2023 Category 2 list through the July 2026 PCAC votes and the recent White House interim policy push.Phoebe explains why something being compoundable does not equal “approved to prescribe,” highlights enforcement coming from FDA warning letters, pharmaceutical lawsuits, and state medical boards, and gives practical questions clinicians and telemedicine companies should ask before adding peptides to their offerings. The episode ends with a clear message: peptides are neither fully approved nor banned, they sit in a rapidly evolving regulatory middle ground where risk is real and documentation matters.Top 3 TakeawaysCompoundable ≠ FDA-approved or safe to prescribe. Availability from a 503A pharmacy does not remove clinical or regulatory risk.Enforcement is coming from four directions at once FDA warning letters, state medical boards, manufacturer lawsuits, and pharmacy investigations. Consent forms and “investigational” language do not eliminate liability.The White House is pushing faster access, but formal Category 1 placement still takes time. Operators who build compliant processes around today’s rules will be best positioned when clearer pathways emerge.About the ShowTelemedicine Talks explores the evolving world of digital health, helping physicians navigate new opportunities, regulatory challenges, and career transitions in telemedicineAbout The HostPhoebe Gutierrez – Former state regulator turned telehealth executive, specializing in compliance and sustainable virtual care models. Connect with Phoebe Gutierrez: https://www.linkedIn.com/in/pkgutierrez/ [email protected](mailto:[email protected]) The information provided in Telemedicine Talks is for educational and informational purposes only and should not be construed as medical, legal, or financial advice. While we discuss best practices, industry trends, and real-world experiences, every situation is unique. Listeners should consult with qualified professionals before making decisions related to telemedicine practice, compliance, contracts, or business operations. The views expressed by the hosts and guests are their own and do not necessarily reflect those of any organizations they may be affiliated with. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More episodes of Telemedicine Talks

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.